Pharmacotherapy: Alcohol and Opioid Use Disorders
Dates: September 3, 2026
Meets: Th from 9:00 AM to 11:15 AM
Location: Zoom Webinar
Zoom - No Charge: $0.00
There are still openings remaining at this time.
The growing knowledge of alcohol's neurobiological effects on the brain has led to the development of effective FDA-approved pharmacotherapy options for use in the treatment of alcohol use disorder. The high prevalence of untreated opioid use disorder and continued increase in opioid-related overdoses nationwide has also created a greater need to increase access and availability to the three medications approved by the FDA to treat opioid use disorder. Instructors will discuss the high prevalence, morbidity, and mortality associated with alcohol and opioid use disorders and the current evidence, effectiveness, and pharmacological profiles of the current FDA-approved pharmacotherapies indicated.
Participants will review prescribing guidelines and protocols for each of the FDA-approved pharmacotherapy options, general patient and medications considerations in treatment selection, and special considerations for high-risk and specific patient populations.
Objectives:
- Discuss the current practice guidelines for screening, assessment, and treatment planning for alcohol and opioid use disorder.
- Describe the current FDA-approved pharmacotherapies for the management of these two disorders.
- Review the current epidemiologic trends and death rates for these disorders.
- Summarize the clinical pharmacology, efficacy, and safety of prescribing for these disorders.
- Recognize the unique patient- and medication-specific considerations when selecting pharmacological treatments.
- Describe best practice recommendations for initiating and stabilizing medications.
Notes:
This event is subject to priority registration. If you have a code, you may register yourself now. If you do not have a registration code, please add yourself to the waitlist. Any registration spots avilable after the priority registration period is over will be awarded on a first-come first-served basis for those on the waitlist.
Certificates for this event are distributed by Hazelden Betty Ford Foundation upon completion of a post-event quiz and evaluation.
If you have any questions about this event, please email learn@midsouth.ualr.edu.
| Fee: | $0.00 |
|---|---|
| Hours: | 2.00 |
Zoom Webinar
Emily Brunner
MD, DFASAM, Physician, TTA Consultant
Dr. Emily Brunner is both certified in family medicine and a distinguished fellow in the field of addiction medicine. She has experience treating addiction in both inpatient and outpatient settings. She is an experienced speaker and specializes in trauma-informed clinical treatment of substance use disorders with a comprehensive and compassionate approach.
Dr. Brunner has been involved in leadership of the Minnesota Society of Addiction Medicine and is now on the national board of the American Society of Addiction Medicine.
